“…For example, the miniaturization of diagnostics may not only provide clinicians with a more complete snapshot of blood chemistries, hormones, and growth factors in both normal and diseases states, but may also allow them to track the efficacy of putative therapeutics [Koehne et al, 2004]. Complementing its diagnostic advances, bionanotechnology also holds the promise of increasing the therapeutic index, a measure of the benefit/risk ratio, of current cancer therapies, as a prime example [Papisov, 1998;Moghimi and Patel, 1998;Woodle, 1998;Nafayasu et al, 1999;Maruyama et al, 1999].…”